Trials / Completed
CompletedNCT01359774
31P-MRS and Huntington Disease
31Phosphorus-Magnetic Resonance Spectroscopy and Huntington Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to identify and quantify a brain energy deficit in Huntington patients, using 31P-RMN spectroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 31P-MR spectroscopy | Brain energy deficit is quantified using 31P-MR spectroscopy |
| OTHER | 31P-RMN spectroscopy | Brain energy deficit is quantified using 31P-RMN spectroscopy |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2011-05-25
- Last updated
- 2025-08-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01359774. Inclusion in this directory is not an endorsement.